vers la météo de la validation par utilisateur

Ingenuity376

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 78 - PMID ?

__NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                                                     +--------------------------COMP:V-N(to)--------------------------+       
     +--------------------SUBJ:V-N-------------------+                                  +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |                                  |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |                                  |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                      |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |                      |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,III)
COMP:V-N(to) (be,degeneration)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 1 
                                                     +--------------------------COMP:V-N(in)--------------------------+       
                                                     |           +---------------------MOD_ATT:N-N--------------------+       
                                                     |           |             +--------------MOD_ATT:N-N-------------+       
     +--------------------SUBJ:V-N-------------------+           |             |        +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |           |             |        |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |           |             |        |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       |           |             |        |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |             |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,degeneration)
MOD_ATT:N-N (degeneration,III)
MOD_ATT:N-N (degeneration,trial)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 2 
                                                     +--------------------------COMP:V-N(in)--------------------------+       
                                                     |      +-----------------------MOD_ATT:N-N-----------------------+       
                                                     |      |    +---------------------MOD_ATT:N-N--------------------+       
                                                     |      |    |             +--------------MOD_ATT:N-N-------------+       
     +--------------------SUBJ:V-N-------------------+      |    |             |        +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |      |    |             |        |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |             |        |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       |      |    |             |        |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |      |    |             |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,degeneration)
MOD_ATT:N-N (degeneration,phase)
MOD_ATT:N-N (degeneration,III)
MOD_ATT:N-N (degeneration,trial)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 3 
     +--------------------SUBJ:V-N-------------------+                                  +-----------OBJ:V-N-----------+       
     |            +-------COMP:N-N(of)-------+       |                                  |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)-----------+    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                      |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |                      |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,III)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,degeneration)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 4 
                                                     +--------------------------COMP:V-N(to)--------------------------+       
     +--------------------SUBJ:V-N-------------------+                                  +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |                                  |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |                                  |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                      |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |                      |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,III)
COMP:V-N(to) (be,degeneration)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 5 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 6 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  |          +--------OBJ:V-N--------+                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 7 
                                                     +--------------------------COMP:V-N(in)--------------------------+       
                                                     |           +---------------------MOD_ATT:N-N--------------------+       
                                                     |           |             +--------------MOD_ATT:N-N-------------+       
     +--------------------SUBJ:V-N-------------------+           |             |        +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |           |             |        |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |           |             |        |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       |           |             |        |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |             |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,degeneration)
MOD_ATT:N-N (degeneration,III)
MOD_ATT:N-N (degeneration,trial)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 8 
                                                     +--------------------------COMP:V-N(in)--------------------------+       
                                                     |      +-----------------------MOD_ATT:N-N-----------------------+       
                                                     |      |    +---------------------MOD_ATT:N-N--------------------+       
                                                     |      |    |             +--------------MOD_ATT:N-N-------------+       
     +--------------------SUBJ:V-N-------------------+      |    |             |        +---------MOD_ATT:N-N---------+       
     |            +-------COMP:N-N(of)-------+       |      |    |             |        |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |             |        |    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       |      |    |             |        |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |      |    |             |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,degeneration)
MOD_ATT:N-N (degeneration,phase)
MOD_ATT:N-N (degeneration,III)
MOD_ATT:N-N (degeneration,trial)
MOD_ATT:N-N (degeneration,treat)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 9 
     +--------------------SUBJ:V-N-------------------+                                  +-----------OBJ:V-N-----------+       
     |            +-------COMP:N-N(of)-------+       |                                  |    +-------MOD_ATT:N-N------+       
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)-----------+    |     +---MOD_ATT:N-ADJ--+       
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                      |    |     |       +MOD_ATT:N-+       
     |            |          |       |       |       |           |                      |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,III)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,degeneration)
MOD_ATT:N-N (degeneration,age)
MOD_ATT:N-ADJ (degeneration,relate)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 10 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +-----------------COMP:N-N(in)-----------------+      |                          |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,III)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 11 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +-----------------COMP:N-N(in)-----------------+      |                          |                          
                  |          +--------OBJ:V-N--------+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,III)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 12 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                  +----------MOD_POST:N-ADJ----------+                          |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_POST:N-ADJ (__NODE__,clinical)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 13 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |          +--------------MOD_POST:N-ADJ--------------+                          |                          
                  |          +--------OBJ:V-N--------+                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_POST:N-ADJ (__SP__,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 14 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |           +--------MOD_ATT:N-N--------+     |                          
                  |                                  |           |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 15 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |           +--------MOD_ATT:N-N--------+     |                          
                  |                                  |           |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 16 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +--------------OBJ:V-N-------------+                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 17 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +--------------OBJ:V-N-------------+                  |                          |                          
                  +---COMP:N-N(of)---+               |                  +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+COMP:V-N(in+      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,III)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 18 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |      +-----------MOD_ATT:N-N----------+     |                          
                  |                                  |      |    +--------MOD_ATT:N-N--------+     |                          
                  |                                  |      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 19 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |           +--------MOD_ATT:N-N--------+     |                          
                  |                                  |           |      +----MOD_ATT:N-ADJ---+     |                          
                  +--------------OBJ:V-N-------------+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 20 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |      +-----------MOD_ATT:N-N----------+     |                          
                  |                                  |      |    +--------MOD_ATT:N-N--------+     |                          
                  |                                  |      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 21 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |           +--------MOD_ATT:N-N--------+     |                          
                  +--------------OBJ:V-N-------------+           |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+               |           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 22 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |      +-----------MOD_ATT:N-N----------+     |                          
                  |                                  |      |    +--------MOD_ATT:N-N--------+     |                          
                  |                                  |      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +--------------OBJ:V-N-------------+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 23 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                                  +--------------COMP:V-N(in)-------------+     |                          
                  |                                  |      +-----------MOD_ATT:N-N----------+     |                          
                  |                                  |      |    +--------MOD_ATT:N-N--------+     |                          
                  +--------------OBJ:V-N-------------+      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+               |      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:V-N(in) (be,age)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 24 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                  +----------MOD_POST:N-ADJ----------+                          |                          
                  |                  +--------COMP:N-N(in)-------+      |                          |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (__NODE__,III)
MOD_POST:N-ADJ (__NODE__,clinical)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 25 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |          +--------------MOD_POST:N-ADJ--------------+                          |                          
                  |          +------------COMP:N-N(in)-----------+      |                          |                          
                  |          +--------OBJ:V-N--------+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (__SP__,III)
MOD_POST:N-ADJ (__SP__,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 26 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  |                  +--------COMP:N-N(in)-------+      |                          |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (__NODE__,III)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 27 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  |          +------------COMP:N-N(in)-----------+      |                          |                          
                  |          +--------OBJ:V-N--------+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
MOD_POST:N-ADJ (agonist,clinical)
COMP:N-N(in) (__SP__,III)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 28 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                              +--------MOD_ATT:N-N--------+     |                          
                  |                                              |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 29 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                              +--------MOD_ATT:N-N--------+     |                          
                  |                                              |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 30 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +-----------------COMP:N-N(in)-----------------+      |                          |                          
                  +--------------OBJ:V-N-------------+           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,III)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 31 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +--------------------MOD_POST:N-ADJ-------------------+                          |                          
                  +-----------------COMP:N-N(in)-----------------+      |                          |                          
                  +--------------OBJ:V-N-------------+           |      |                          |                          
                  +---COMP:N-N(of)---+               |           |      +---COMP:ADJ-N(to)---+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |               +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |               |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,III)
MOD_POST:N-ADJ (agonist,clinical)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
COMP:ADJ-N(to) (clinical,age)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 32 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                         +-----------MOD_ATT:N-N----------+     |                          
                  |                                         |    +--------MOD_ATT:N-N--------+     |                          
                  |                                         |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 33 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                         +-----------MOD_ATT:N-N----------+     |                          
                  |                                         |    +--------MOD_ATT:N-N--------+     |                          
                  |                                         |    |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 34 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                  +----------------------COMP:N-N(in)---------------------+     |                          
                  |                  |                           +--------MOD_ATT:N-N--------+     |                          
                  |                  |                           |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (__NODE__,age)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 35 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |          +--------------------------COMP:N-N(in)-------------------------+     |                          
                  |          |                                   +--------MOD_ATT:N-N--------+     |                          
                  |          |                                   |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (__SP__,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 36 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |                  +----------------------COMP:N-N(in)---------------------+     |                          
                  |                  |                      +-----------MOD_ATT:N-N----------+     |                          
                  |                  |                      |    +--------MOD_ATT:N-N--------+     |                          
                  |                  |                      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+----OBJ:V-N----+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (__NODE__,age)
OBJ:V-N (be,__NODE__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 37 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  |          +--------------------------COMP:N-N(in)-------------------------+     |                          
                  |          |                              +-----------MOD_ATT:N-N----------+     |                          
                  |          |                              |    +--------MOD_ATT:N-N--------+     |                          
                  |          |                              |    |      +----MOD_ATT:N-ADJ---+     |                          
                  |          +--------OBJ:V-N--------+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (__SP__,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,__SP__)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 38 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                              +--------MOD_ATT:N-N--------+     |                          
                  |                                              |      +----MOD_ATT:N-ADJ---+     |                          
                  +--------------OBJ:V-N-------------+           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 39 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                              +--------MOD_ATT:N-N--------+     |                          
                  +--------------OBJ:V-N-------------+           |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+               |           |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+           |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |           |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 40 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                         +-----------MOD_ATT:N-N----------+     |                          
                  |                                         |    +--------MOD_ATT:N-N--------+     |                          
                  |                                         |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +--------------OBJ:V-N-------------+      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  +COMP:N-N(o+       +MOD_ATT+SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__SP__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)
Analyse 41 
                  +------------------------------------SUBJ:V-N------------------------------------+                          
                  +-------------------------------COMP:N-N(in)-------------------------------+     |                          
                  |                                         +-----------MOD_ATT:N-N----------+     |                          
                  |                                         |    +--------MOD_ATT:N-N--------+     |                          
                  +--------------OBJ:V-N-------------+      |    |      +----MOD_ATT:N-ADJ---+     |                          
                  +---COMP:N-N(of)---+               |      |    |      |      +-MOD_ATT:N-N-+     +------OBJ:V-N-----+       
                  |          +MOD_ATT+       +SUBJ:V-+      |    |      |      |        +MOD_+     |       +MOD_ATT:N-+       
                  |          |       |       |       |      |    |      |      |        |    |     |       |          |       
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase III clinical trial to treat age related macular degeneration .
COMP:N-N(of) (agonist,__NODE__)
COMP:N-N(in) (agonist,age)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (be,agonist)
SUBJ:V-N (be,protein)
MOD_ATT:N-N (age,phase)
MOD_ATT:N-N (age,III)
MOD_ATT:N-ADJ (age,clinical)
MOD_ATT:N-N (age,trial)
MOD_ATT:N-N (age,treat)
SUBJ:V-N (relate,agonist)
OBJ:V-N (relate,degeneration)
MOD_ATT:N-ADJ (degeneration,macular)